PF Equity Holdings 2 B.V. - Sep 10, 2021 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
10%+ Owner
Signature
Susan E. Grant, Attorney-in-fact on behalf of PF Equity Holdings 2 B.V.
Stock symbol
ALLO
Transactions as of
Sep 10, 2021
Transactions value $
$0
Form type
3
Date filed
9/20/2021, 06:25 PM
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALLO Common Stock 22M Sep 10, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired from its parent entity, Pfizer Inc. for no cash consideration.

Remarks:

poa2n.htm